Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class ITerminatedSep 24, 2014Xzen 1200Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Xzen 1200 because FDA laboratory analysis determined they...Nova Products, Inc. · D-1600-2014Class ITerminatedSep 24, 2014XZEN PLATINUMMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN PLATINUM because FDA laboratory analysis determined they...Nova Products, Inc. · D-1599-2014Class ITerminatedSep 24, 2014XZEN GOLDMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN GOLD because FDA laboratory analysis determined they...Nova Products, Inc. · D-1598-2014Class ITerminatedSep 24, 2014Black AntMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Black Ant because FDA laboratory analysis determined they...Nova Products, Inc. · D-1597-2014Class ITerminatedSep 24, 2014AFRICAN BLACK ANTMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined...Nova Products, Inc. · D-1596-2014Class ITerminatedSep 24, 2014COUMADIN FOR INJECTIONPresence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vialsBristol-Meyers Squibb · D-1595-2014Class ITerminatedSep 24, 2014THINOGENICSMarketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.Nature's Universe · D-1594-2014Class ITerminatedSep 24, 2014Potassium Chloride InjectionPresence of Particulate Matter: particulate matter identified as fibers and/or plasticsBaxter Healthcare Corp. · D-1593-2014Class ITerminatedSep 24, 20140.9% Sodium Chloride Injection USP MINI-BAG Plus ContainerPresence of Particulate Matter: particulate matter identified as fibers and/or plastics.Baxter Healthcare Corp. · D-1592-2014Class ITerminatedSep 24, 20140.9% Sodium Chloride Injection USPPresence of Particulate Matter: particulate matter identified as fibers and/or plastics.Baxter Healthcare Corp. · D-1591-2014Class ITerminatedSep 24, 2014Oxcarbazepine TabletsLabeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were...American Health Packaging · D-1590-2014Class ITerminatedSep 24, 2014Ibuprofen TabletsLabeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were...American Health Packaging · D-1589-2014Class IITerminatedSep 24, 2014Bupivacaine HCl InjPresence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.Hospira Inc. · D-1588-2014Class IITerminatedSep 24, 2014NORepinephrine 4 mg in 250 mL Sodium Chloride0.9%Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production.Unique Pharmaceutical, Ltd · D-1587-2014Class IITerminatedSep 24, 2014Dermatend UltraLabeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the...Solace International Inc · D-1586-2014Class IITerminatedSep 24, 2014Dermatend OriginalLabeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the...Solace International Inc · D-1585-2014Class IIITerminatedSep 24, 2014Warfarin Sodium TabletsFailed Content Uniformity Specifications.Taro Pharmaceuticals U.S.A., Inc. · D-1584-2014Class IIITerminatedSep 24, 2014Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mgFailed Impurity/Degradation Specification; high out of specification for CAD II degradantApotex Corp. · D-1570-2014Class IITerminatedSep 17, 20140.9% Sodium Chloride InjectionLack of Assurance of Sterility; complaints of mold in the overpouchBaxter Healthcare Corp. · D-1583-2014Class IIITerminatedSep 17, 2014CHIROTHIN Dietary SupplementMarketed without an Approved NDA/ANDA; Product contains unapproved hHCG.ChiroNutraceutical LLC · D-1569-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Tablets 40 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1582-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Tablets 20 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1581-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Tablets 10 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1580-2014Class IITerminatedSep 10, 2014PAXIL CRChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1579-2014Class IITerminatedSep 10, 2014PAXIL CRChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1578-2014Class IITerminatedSep 10, 2014Paroxetine HCL Controlled-Release Tablets 37.5 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1577-2014Class IITerminatedSep 10, 2014Paroxetine HCL Controlled-Release Tablets 25 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1576-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottleChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1575-2014Class IITerminatedSep 10, 2014Paroxetine HCL Controlled-Release Tablets 12.5 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1574-2014Class IITerminatedSep 10, 2014Comfort Shield Barrier Cream Cloths with dimethicone a)Microbial Contamination of Non-Sterile Products: Comfort Shield Barrier Cream Cloth packages tested positive for bacterial contamination.Sage Products Inc · D-1573-2014Class IITerminatedSep 10, 2014OXYCODONE and ACETAMINOPHENFailed Tablet/Capsule Specifications: Broken tablets found in sealed bottles.Qualitest Pharmaceuticals · D-1572-2014Class ITerminatedSep 3, 2014Atropine Sulfate 0.4 mg/ml InjectionIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1568-2014Class IITerminatedSep 3, 2014Glycopyrrolate 0.2 mg/mlIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1567-2014Class ITerminatedSep 3, 2014Midazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bagIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1566-2014Class ITerminatedSep 3, 2014Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC VialIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1565-2014Class IITerminatedSep 3, 2014All Unexpired Sterile Drug ProductsLack of Assurance of SterilityAbrams Royal Pharamacy · D-1564-2014Class ITerminatedSep 3, 2014MINERAL IV InjectionNon-Sterility; analytical results found product to contain Sphingomonas paucimobilisAbrams Royal Pharamacy · D-1563-2014Class ITerminatedSep 3, 2014LOW Potassium Cardioplegia 792 mLNon Sterility; microbial contamination identified as Aspergillus speciesCentral Admixture Pharmacy Services, Inc. · D-1562-2014Class ITerminatedSep 3, 2014adenosine 90 mg in 0.9% sodium chloride/90 mLNon Sterility; microbial contamination identified as Aspergillus speciesCentral Admixture Pharmacy Services, Inc. · D-1561-2014Class ITerminatedSep 3, 2014del Nido Cardioplegia with Lidocaine 1052.8 mlNon Sterility; microbial contamination identified as Aspergillus speciesCentral Admixture Pharmacy Services, Inc. · D-1560-2014

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.